Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jeffrey Xia"'
Autor:
Jeffrey Xia, Kinan Bachour, Abdul-Rahman M. Suleiman, Jacob S. Roberts, Sammy Sayed, Geoffrey W. Cho
Publikováno v:
Therapeutic Advances in Cardiovascular Disease, Vol 18 (2024)
Coronary computed tomography angiography (CCTA) is a noninvasive imaging modality of cardiac structures and vasculature considered comparable to invasive coronary angiography for the evaluation of coronary artery disease (CAD) in several major cardio
Externí odkaz:
https://doaj.org/article/922229aa838549ffb593e16f9a7e8241
Autor:
Jeffrey Xia, Rasha Ahmed
Publikováno v:
IDCases, Vol 37, Iss , Pp e02027- (2024)
HSV-1 encephalitis (HSE) is the most common cause of fatal sporadic encephalitis in the United States. HSE in adults is most commonly due to the reactivation of HSV in the central nervous system (CNS) which results in CNS necrosis leading to neurolog
Externí odkaz:
https://doaj.org/article/a728e1b6530943d7855ddeabd38131e8
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa9f1bee46b908772e8fdd86e4cc8c76
https://doi.org/10.2139/ssrn.4365144
https://doi.org/10.2139/ssrn.4365144
Publikováno v:
Cureus
Murine (endemic) typhus is a zoonotic disease spread by fleas carrying Rickettsia typhi bacteria. Typically, murine typhus presents with mild and nonspecific flu-like symptoms. However, it can manifest with severe systemic complications potentially l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46bd23eade8c61495c2753a9a7e6402f
http://europepmc.org/articles/PMC8638779
http://europepmc.org/articles/PMC8638779
Publikováno v:
J Gastrointest Oncol
BACKGROUND: In the last four years, six regimens were approved by the Food and Drug Association as second-line therapies for advanced hepatocellular carcinoma (HCC). However, there are significant differences between real-world and clinical trial pop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c931dca3e0d064881c014e2802cbb2
https://pubmed.ncbi.nlm.nih.gov/35070420
https://pubmed.ncbi.nlm.nih.gov/35070420
Autor:
Huynh Cao, Jeffrey Xiao, David J. Baylink, Vinh Nguyen, Nathan Shim, Jae Lee, Dave J. R. Mallari, Samiksha Wasnik, Saied Mirshahidi, Chien-Shing Chen, Hisham Abdel-Azim, Mark E. Reeves, Yi Xu
Publikováno v:
Biomedicines, Vol 12, Iss 10, p 2250 (2024)
Background: T-cell-based adoptive cell therapies have emerged at the forefront of cancer immunotherapies; however, failed long-term survival and inevitable exhaustion of transplanted T lymphocytes in vivo limits clinical efficacy. Leukemia blasts pos
Externí odkaz:
https://doaj.org/article/ebb1a91ed9ef452bb180d39522240859
Publikováno v:
Journal of Clinical Oncology. 39:271-271
271 Background: Within the last 4 years, the FDA approved five drugs as second-line therapies for advanced HCC. At our cancer center, the majority of our patients are Hispanic with varying liver dysfunction, and this real world population is not repr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9775f09355996a449acff6801dd9b65
https://doi.org/10.1200/jco.2021.39.3_suppl.271
https://doi.org/10.1200/jco.2021.39.3_suppl.271
Publikováno v:
Journal of Nutrition Education and Behavior. 52:S77
Objective To demonstrate efficacy of a web-based intervention on nutritional counseling for medical, nursing, and health professions students in improvement in 2 areas: objective nutrition knowledge and self-reported confidence in providing nutrition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49cecc161a915873901a7e2f35f8d960
https://doi.org/10.1016/j.jneb.2020.04.176
https://doi.org/10.1016/j.jneb.2020.04.176
Autor:
Sukeshi Patel Arora, Jeffrey Xia
Publikováno v:
Journal of Clinical Oncology. 38:e16676-e16676
e16676 Background: Hispanics have a higher incidence of HCC but are underrepresented in clinical trials leading to approvals of new therapies for HCC. Further, there is a lack of prospective trials comparing second-line treatments for HCC. Therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b509231aa328c88a25c6fcace92a08a
https://doi.org/10.1200/jco.2020.38.15_suppl.e16676
https://doi.org/10.1200/jco.2020.38.15_suppl.e16676
Autor:
Yi Xu, David J. Baylink, Chien-Shing Chen, Laren Tan, Jeffrey Xiao, Brandon Park, Ismael Valladares, Mark E. Reeves, Huynh Cao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Acute myeloid leukemia (AML) patients have frequent mutations in FMS-like receptor tyrosine kinase 3 (FLT3-mut AML), who respond poorly to salvage chemotherapies and targeted therapies such as tyrosine kinase inhibitors (TKIs). Disease relapse is a c
Externí odkaz:
https://doaj.org/article/04222e2a69dc42e88e95be578473bd6b